Navigation Links
TenX Biopharma Licenses Zanolimumab From Genmab
Date:2/4/2010

PHILADELPHIA, Feb. 4 /PRNewswire/ -- TenX Biopharma, Inc. announced today it has signed a licensing agreement to acquire exclusive worldwide rights to develop and commercialize zanolimumab (HuMax-CD4®) from Genmab A/S (OMX: GEN).

Under the terms of the agreement, Genmab will receive an up-front license fee of USD 4.5 million and will be entitled to milestones and royalties on sales of zanolimumab.  TenX will be responsible for all future costs of developing, manufacturing and commercializing zanolimumab.  

"Zanolimumab has promise for treatment of patients with T cell cancers, and potential in other cancer types for which existing therapies are inadequate," said Gardiner F.H. Smith, Chief Executive Officer of TenX Biopharma. "We are building a pipeline of new medicines for high unmet need, with a focus on the patient through business efficiency."

Asher Nathan, Managing Partner of Zoticon Bioventures and the lead investor in TenX, said "TenX and zanolimumab represent the fourth late stage drug funding which we've led in the past two years.  I'm delighted that this important product will be available in the future, and look forward to the management team at TenX continuing to build value with novel cancer therapeutics."

"Genmab is pleased to find a partner who wishes to take zanolimumab forward in development," said Lisa N. Drakeman, Ph.D., Chief Executive Officer.  "This is good news for patients who may one day benefit from treatment with zanolimumab."

About TenX

TenX is a biopharmaceutical company focused on late stage development and launch of novel cancer products.  For more information visit

SOURCE TenX Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 Aufgrund ... den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch ... PDF, verfügbar unter pharmaserialisation.com , zeigt die ... jeweils in Kraft treten. Für international ... länger um das "ob", sondern darum, "wann" sie ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
(Date:9/19/2014)... Sept. 19, 2014 Intarcia Therapeutics, Inc. ... data for its lead candidate ITCA 650 (continuous subcutaneous ... high baseline HbA1c levels at the 50 th ... of Diabetes (EASD). Data from the open-label, phase 3 ... blood sugar in patients with poorly controlled type 2 ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... Ill., April 7, 2011 MinuteClinic, the ... CVS ), has entered into a clinical affiliation ... enhance the high quality, affordable health care services provided ... It is the largest clinical collaboration between a regional ...
... A study published in the journal ... third-largest health system, has achieved remarkable results in eliminating ... and keeping patients safe.  In 2003, Ascension Health set ... Ascension Health has seen consistent improvement over the eight ...
Cached Medicine Technology:New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 3New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 4Study Highlights Successes of Ascension Health Quality Initiative 2
(Date:9/19/2014)... Internationally acclaimed prosthodontist and presenter Dr. Saj Jivraj ... , Dr. Jivraj, founder of a Ventura contemporary ... Institute, will speak about All-on-4™ dental implants ... Graft Less Solutions.” He is speaking at 12:40 p.m. ... & Conference Centre in Vancouver, British Columbia, Canada. , ...
(Date:9/19/2014)... Germany (PRWEB) September 19, 2014 ... that its new ND® Infusion Catheter is ... of Frankfurt. , The study commenced on September 4th, ... The use of the new catheter demonstrated a number ... known as stem cells. “We are at the forefront ...
(Date:9/19/2014)... Cancer researchers in Japan have identified ... where mesothelioma develops in the body. Click here ... important research. , Doctors with Nara Medical University ... mesothelioma (on the lung lining) and those with ... suggests that the pathway of the genetic abnormality might ...
(Date:9/19/2014)... September 19, 2014 In their ... find affordable home care options, Seniors Guide has ... on http://www.HomeCareChoice.com - their website ... in Virginia, North Carolina, Ohio, and Indiana. , ... licensing, costs, services offered, training and education, and ...
(Date:9/19/2014)... New York, NY (PRWEB) September 19, 2014 ... offers free Rx discounts on all commonly prescribed ... provider of free online drug coupons and has ... To further its mission of making prescription medications ... on all common high blood pressure medications. , ...
Breaking Medicine News(10 mins):Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 2Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 3Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 4Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 5Health News:First-in-man procedure utilizes a new method of stem cell delivery 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 3Health News:New Study Finds Link Between Genes and Mesothelioma Location, Reports Surviving Mesothelioma 2Health News:Seniors Guide Offers Advice on How to Find the Right Home Health Care Agency 2Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 2Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 3
... Health has awarded $10.24 million to Fred Hutchinson Cancer ... to understand and prevent breast cancer disparities in Hispanic ... nationwide to receive funding as part of the NIH ... is launching a major new effort to understand and ...
... a specific type of dopamine receptor gene respond ... without the genotype, according to new research from ... come from the first-ever placebo-controlled pharmacogenetic drug trial ... to evaluate variants of the DRD4 dopamine receptor ...
... According ... the ages of 25 and 34 report being taught to practice defensive medicine. , ... Atlanta, GA (PRWEB) May 3, 2010 -- According to ... of physicians between the ages of 25 and 34 report being taught to practice defensive medicine., ...
... ... National Lupus Awareness Month 2010 with a 115-sq-ft display window at 10 Rockefeller Plaza to ... in the heart of New York City, was generously donated by EHE International for the ... (PRWEB) ...
... Mass. -- Our DNA is under constant siege from a ... of cells to repair that damage has broad health implications, ... used to study DNA damage are quite limited, but MIT ... analysis that promises to make an impact on human health. ...
... 3, 2010) The results of new research results ... of the American College of Surgeons show that ... a hospital surgical ward. Postoperative pneumonia is ... third most common infectious complication after urinary tract and ...
Cached Medicine News:Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 2Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 3Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 4Health News:Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research 5Health News:Research helps end guesswork in prescribing ADHD drug 2Health News:Young Physicians Taught to Practice Defensive Medicine, Survey Finds 2Health News:Young Physicians Taught to Practice Defensive Medicine, Survey Finds 3Health News:Lupus Awareness Month Kicks Off at Rockefeller Center: EHE International Donates Display Window to S.L.E. Lupus Foundation for May 2Health News:Lupus Awareness Month Kicks Off at Rockefeller Center: EHE International Donates Display Window to S.L.E. Lupus Foundation for May 3Health News:Rapid analysis of DNA damage now possible 2Health News:Surgeons' pilot prevention program reduces incidence of postoperative pneumonia 2
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring heart and breath sounds....
Medicine Products: